Semaglutide Demand is Skyrocketing: Ozempic Opportunities

As summer approaches, soaring demand for weight-loss drugs like Ozempic, Wegovy, and semaglutide compounded copies, will exacerbate the existing short-supply, raising both consumer prices and pharmacy profits for those positioned to capitalize.

View Article >>

Semaglutide Compounding Pharmacies Subject to Increasing Regulatory Threats

Semaglutide compounding pharmacies face regulatory threats as state boards interpret statutes restrictively; Health Law Alliance, led by Anthony Mahajan, emphasizes broader permissions, countering misinterpretations.

View Article >>